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ABSTRACT
The impact of intestinal parasitic infection in renal transplant recipients requires careful consid-
eration in the developing world. However, there have been very few studies addressing this issue 
in Iran. This study was conducted to determine the prevalence of intestinal parasitic infections in 
renal transplant recipients in Iran. Stool specimens from renal transplant recipients and control 
groups were obtained between June 2006 and January 2007. The samples screened for intesti-
nal parasitic infections using direct smear, formalin-ether sedimentation, Sheather’s flotation and 
modified Ziehl-Neelsen staining methods. Out of 150 renal transplant recipients, 33.3% (50), and 
out of 225 control group, 20% (45) were infected with one or more type of intestinal parasites. 
The parasites detected among patients included Entamoeba coli (10.6%), Endolimax nana (8.7%), 
Giardia lamblia (7.4%), Blastocystis spp. (4.7%), Iodamoeba butschlii (0.7%), Chilomastix mesnili 
(0.7%) and Ascaris lumbricoides (0.7%). Multiple infections were more common among renal 
transplant recipients group (p < 0.05). This study highlights the importance of testing for intes-
tinal parasites among Iranian renal transplant recipients. Routine examinations of stool samples 
for parasites would significantly benefit the renal transplant recipients by contributing to reduce 
severe infections.
Keywords: intestinal parasites, renal transplant recipients, prevalence.
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Intestinal parasitic infections in renal transplant recipients
INTRODUCTION
About 340 parasitic species infect more than 
three billion people worldwide with varying 
morbidity and mortality.1 Infections cause 
significant morbidity and mortality among 
immunosupressed hosts. Acquisition of infec-
tion, clinical severity, and outcome of a para-
sitic disease depend on innate and acquired 
host immunity as well as on the parasites’ own 
response against the host when the infection 
is established. The incidence and prevalence 
of parasitic infections in transplant recipi-
ents is unknown since only a few patients are 
symptomatic.2 Only 5% of known human-
pathogenic parasitic infections have been re-
ported in transplant recipients. This certainly 
does not represent the true prevalence because 
only those infections that cause significant 
morbidity would be expected to find their 
way in to the literature.1 Since the use of cy-
closporine has become a cornerstone in pro-
phylactic immunosuppression, this syndrome 
has become exceedingly rare, owing to the 
strong parasiticidal effect of the drug against 
a wide range of organisms, as documented in 
mice and humans.1,3 The new immunosup-
pressive drugs used to prevent graft rejection 
have lead to an increase in parasitic infections 
in renal transplant recipients. The purpose of 
our study was to evaluate the prevalence of in-
testinal parasites in renal transplant recipients 
and compare with healthy individuals. 
MATERIAL AND METHODS
This cross-sectional study was conducted from 
June 2006 to January 2007 at Nor hospital, a 
referral hospital for kidney transplantation in 
Isfahan, Iran. Stool specimens were collected 
from 150 renal transplant recipients and 225 
non-immunosuppressed cases that were from 
different wards and selected randomly as the 
control group. These samples were examined 
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microscopically following direct and formalin-ether concen-
tration method.4 In brief, samples were collected in labeled, 
leak-proof, and clean plastic stool cups and brought to the 
laboratory immediately. Direct microscopy of the smears in 
a saline (0.85% NaCl solution) and Lugol’s iodine was per-
formed for the detection of ova, larvae, trophozoites, and 
cysts of intestinal parasites. In addition, a concentration pro-
cedure was employed that involved mixing the stool samples 
with formalin, treating with ether, centrifuging afterwards. 
The layers of ether, formalin, and debris were discarded, 
and the residues were used to investigate for the presence 
of intestinal parasites.4 Also, we used of Sheather’s flotation 
method and modified Ziehl-Neelsen staining technique for 
detection of coccidian parasites.
The data was analyzed using SPSS version 13 statistical 
package. A comparison of the frequency of parasites between 
cases and controls was performed by chi-square test. Subse-
quently, the Wilcoxon Rank Sum test was used to compare 
multiple parasitic infections in cases and controls. p value 
< 0.05 was considered significant.
RESULTS
A total 375 fecal samples were collected for this study. 150 
were renal transplant recipients with a mean age of 42 years. 
Of these, 104 (69.4%) were males and 46 (30.6%) were fe-
males (Table 1). The control group included 225 subjects 
(Table 1). There were no statistically significant differences 
between males and females in two groups (p > 0.05).
Intestinal parasites were detected in 33.3% of the renal 
transplant recipients and in 20% of the control. Table 2 
shows the prevalence of intestinal parasites detected in the 
study subjects. No statistically significant difference in prev-
alence of individual parasite species was detected between 
cases and controls (p > 0.05). Protozoa intestinal parasites 
were most common than helminthes both in renal trans-
plant recipients (29.4% versus 0.7%) and in controls (19.2% 
versus 0.9%) (Table 2), p < 0.05.
Table 3 shows the magnitude of single and multiple para-
sitic infections in renal transplant recipients and in controls. 
Multiple parasitic infections were observed in a total of 15 
renal transplant recipients and 20 controls (p < 0.05). The 
species of parasites most frequently seen in multiple infec-
tions in renal transplant recipients were Entamoeba coli and 
Blastocystis spp.
DISCUSSION
Protozoa and helminthes are among the most important 
pathogens that can cause infections in immunocompromised 
hosts. These microorganisms particularly infect individuals 
with impaired cellular immunity; such as those with hema-
tological malignancies, renal or heart transplant patients, pa-
tients using high doses of corticosteroids, and patients with 
acquired immunodeficiency syndrome.5
In this study, we evaluated the prevalence of intestinal 
parasites in renal transplant recipients, comparing to healthy 
individuals. According to the results the overall prevalence’s of 
either helminthes or protozoan parasites were not statistically 
different between two groups. This observation may agree 
with several reports stating that intestinal parasitic infec-
tions in immunocompromised patients depend largely on the 
prevalence of intestinal parasitism in the local community.6,7 
Prevalence of intestinal parasites in renal transplant recip-
ients are not known in Iran, so we had to compare our results 
to other studies on immunocompromised individuals such as 
HIV patients. Intestinal parasitic infection did not appear to 
be highly prevalent in our population. An intermediate to low 
level of prevalence was found in comparison with data from 
prevalence studies carried out in other regions.8,9 In a recent 
study carried out on renal transplant recipients, the overall 
prevalence of intestinal parasites was 2.4%.10
In the present study, E. coli was the first most prevalent 
parasite detected in both groups, without significant differ-
ence and followed by Endolimax nana and Giardia lamblia. 
In a recent study in Iran, rate of infection with E. coli, E. nana 
Table 1. Age and sex distribution of renal transplant recipients and controls
                                                      renal transplant recipients                                                   Controls
        Age Male Female Male Female
 No. (%) No. (%) No. (%) No. (%)
<20 years 1 (1) 4 (8.7) 23 (19.5) 30 (28)
21-35 years 30 (28.8) 14 (30.4) 28 (23.7) 39 (36.4)
36-50 years 41 (39.4) 10 (21.7) 26 (22) 23 (21.5)
51-65 years 27 (26) 13 (28.3) 22 (18.6) 15 (14)
>65 years 5 (4.8) 5 (10.9)  19 (16.1) 0 (0)
Total 104 (69.4) 46 (30.6) 118 (52.5) 107 (47.5)
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and G. lamblia in HIV patients have been reported 0.16%, 
0% and 4.1%, respectively.6. In other study carried out on 
renal transplant recipients in Brazil, G. lamblia was the third 
most prevalent parasite (3/16) and Strongyloides stercoralis 
was the common parasite (11/16) in these patients.10
Cryptosporidium infection is prevalent in communi-
ties with overcrowding and low level sanitation,11 and its 
prevalence reaches up to 36% in certain developing coun-
tries.12 In Iran, the exact coccidian infection rates are not 
known and there are very few studies on cryptosporidi-
osis. The previous reports indicate the prevalence of this 
infection in diarrhea patients of 4.7%13 and in HIV-pa-
tients of 1.5%.6 The isolation rate was low in our sub-
ject (0.4%), compared to control group. This could be 
attributed to the relatively preserved  immune status of 
our study subject.
Cyclospora cayetanensis is an opportunistic protozoan re-
lated to outbreaks, and in endemic areas, causing prolonged 
diarrhea in immunocompetent, as well as, in immunocom-
promised individuals.14 According to our study, none of in-
vestigated specimens were positive to C. cayetanensis infec-
tion. Recently, a study suggested a rare distribution of this 
parasite in Iran, with only two cases reported so far.15,16 
S. stercoralis has the unique feature of transmitting from 
the parasitic form to the infective stage within the body, 
rather than emerging and forming free-living stages, causing 
autoinfection.17 This may lead to latent infection for an in-
definite period in an immunocompetent host, but may also 
cause fatal hyper-disseminated infection organ transplant 
recipients, cancer and other immunosuppressive condi-
tion.18 In the present study, no S. stercoralis were detected in 
both groups. It is a fact that, the use of Cyclosporine A (CsA) 
has become a cornerstone in prophylactic immunosuppres-
sion among renal transplant recipients. Cyclosporine A with 
powerful properties of immunosuppression, acts on para-
sitic infections in various ways.19 There are few articles that 
reported CsA has reduced the incidence of strongyloidiasis 
in renal transplant recipients.1,20 The rate of infection with 
S. stercoralis in HIV-patients in Iran20 and renal transplant 
recipients in Brazil10 have been reported 0.2% and 68.8% 
respectively.
The detection of such common intestinal parasites in both 
patients and controls could be a reflection of the poor environ-
mental sanitation and personal hygienic practices, which em-
phasize the need for intervention measures at the community 
level to reduce the risk factors of acquiring intestinal parasites. 
Table 2. Prevalence of intestinal parasites in renal transplant recipients and controls
Parasite species renal transplant recipients (n = 150) Controls (n = 225)
 No. (%) No. (%)
Entamoeba coli 16 (10.6) 17 (7.6)
Endolimax nana 13 (8.7) 15 (6.7)
Giardia lamblia 11 (7.4) 4 (1.8)
Blastocystis spp. 7 (4.7) 5 (2.2)
Iodamoeba butichilli 1 (0.7) 1 (0.4)
Chilomastix mesnili 1 (0.7) 0 (0)
Cryptosporidium spp. 0 (0) 1 (0.4)
Ascaris lumbricoides 1 (0.7) 0 (0)
Hymnolepis nana 0 (0) 2 (0.9)
All protozoa  49 (29.4) 43 (19.2)
All helminthes 1 (0.7) 2 (0.9)
Total infected 50 (33.3) 45 (20)
Table 3. Single and multiple parasitic infections in renal transplant recipients and controls
  Parasites detected
Subjects One Two Three
 No. (%) No. (%) No. (%)
Renal transplant recipients (n = 150) 135 (90) 12 (8) 3 (2)
Controls (n = 225) 205 (91.2) 5 (2.2) 15 (6.6)
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It was also evident that multiple parasitic infections were 
more common in renal transplant recipients than in con-
trols, which strongly indicates the facilitated establishment 
of parasites in immunocompromised patients. It is very 
important to target these common infections while treating 
renal transplant recipients for opportunistic infections in 
developing countries like Iran.
In conclusion, the magnitude of intestinal parasitic in-
fection was high both in renal transplant recipients and 
controls. Routine examination of stool samples for parasites 
could significantly benefit the renal transplant recipients 
and uninfected individuals by contributing to reduce clini-
cal severity and improved quality of live.
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